Pension funds invest nearly £600m in controversial baby milk producers

Vitamin D guidancePension funds investing on behalf of thousands of doctors, nurses and midwifes are pouring vast sums into companies producing baby milk products which it is claimed are being aggressively marketed abroad “without clear scientific rationale”, an Ecostorm investigation with the i newspaper has found.

The findings come as a new report has accused the four largest manufacturers of baby milk substitutes (BMS) – Swiss-based Nestle, France’s Danone, and American companies Mead Johnson Nutrition and Abbott Laboratories – of differentiating their products across markets based on consumer research rather than hard science.

The Milking It study, led by British-based campaign group the Changing Markets Foundation, found that families in some parts of the world are paying huge premiums compared to parents in places such as the UK in a global market now worth some £36bn a year. In Britain, feeding a two to three-month-old baby with BMS costs up to three per cent of the average salary.

Read more at: